Publications by authors named "S Illsinger"

Claim this Profile
D
Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland-part I-systematic literature review and existing evidence.
Claudia Weiß, Katharina Vill, Matthias Baumann, Günther Bernert, Astrid Blaschek, Sabine Illsinger

J Neuromuscul Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study.
Claudia Weiß, Lena-Luise Becker, Johannes Friese, Astrid Blaschek, Andreas Hahn, Sabine Illsinger

Lancet Reg Health Eur· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postnatal management of preterm infants with spinal muscular atrophy: experience from German newborn screening.
Regina Trollmann, Jessika Johannsen, Katharina Vill, Cornelia Köhler, Andreas Hahn, Sabine Illsinger

Orphanet J Rare Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial.
Oliver Schwartz, Katharina Vill, Michelle Pfaffenlehner, Max Behrens, Claudia Weiß, Sabine Illsinger

JAMA Pediatr· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2.
Katharina Vill, Moritz Tacke, Anna König, Matthias Baumann, Manuela Baumgartner, Sabine Illsinger

J Neurol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis